(-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts

Abstract

(-)-Epigallocatechin gallate (EGCG), the most abundant flavonoid in green tea, and chlorogenic acid, the main polyphenol found in coffee, attract significant attention owing to health benefits. We have previously demonstrated that prostaglandin E₂ (PGE₂) stimulates osteoprotegerin synthesis through the activation of p38 mitogen-activated protein (MAP) kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the effects of EGCG or chlorogenic acid on the PGE₂-stimulated osteoprotegerin synthesis in MC3T3-E1 cells. EGCG significantly amplified the PGE₂-induced release. EGCG markedly enhanced the expression levels of osteoprotegerin mRNA induced by PGE₂. On the contrary, chlorogenic acid had no effect on the PGE₂-stimulated release of osteoprotegerin. EGCG significantly strengthened the PGE₂-induced phosphorylation of p38 MAP kinase and SAPK/JNK, whereas chlorogenic acid failed to affect them. BIRB0796 and SP600125, a p38 MAP kinase inhibitor and a SAPK/JNK inhibitor, respectively, markedly reduced the amplification by EGCG of the PGE₂-stimulated osteoprotegerin release. These results strongly suggest that EGCG synergistically enhances the PGE₂-stimulated osteoprotegerin synthesis via potentiation of p38 MAP kinase and SAPK/JNK in osteoblasts. Our present findings could present a new significant aspect in the favorable effect of EGCG on the prevention of osteoporotic bone loss and fracture especially in elderly people since osteoprotegerin secreted from osteoblasts is well-recognized to act as a suppressor of osteoclastic bone resorption.

Keywords: (-)-Epigallocatechin gallate; Chlorogenic acid; Osteoblast; Osteoprotegerin; PGE(2).